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Radiological sign of a long line in
the ascending lumbar vein
We would like to draw attention to a useful
radiological sign indicating that a percuta-
neous central venous catheter may be in the
ascending lumbar vein. In our neonatal unit
there have been two confirmed cases where
the ascending lumbar vein had inadvertently
been cannulated. In both these cases a loop
in the line had been noted in the region of
the ileo-femoral vein (see figs 1 and 2). This
‘‘looping’’ or bend in the line is also seen in
the picture recently published by De,5 and in
other papers.1–3
That this complication occurs almost exclu-
sively on the left2 has been attributed to the
unique anatomy of the left ileo-femoral vein
compared to the right.1 We believe that the
local anatomy of the left ileo-femoral vein
may also explain why the line loops when
inadvertently entering the left ascending
lumbar vein (fig 3). One can appreciate that,
when the ascending lumbar vein is seen on
the lateral1 and lateral-oblique view,4 and
compared with the anterior posterior view,
the vein can be seen to descend into the
pelvis and then enter the ascending lumbar
vein at an angle. On an x ray the line will
then project a loop or bend.
Another factor that may contribute to the
appearance of the loop or bend is that it is
probably difficult to advance the line up the
narrow ascending lumbar vein, and therefore
when trying to thread the line to its
calculated length the line will ‘‘buckle’’ at
this point.
Any loop or bend of a contrast filled line in
the left ileo-femoral region should be
regarded as a sign that the line has entered
the ascending lumbar vein and pull the line
back because the lumbar venous plexus will
not always be visualised with contrast. There
are serious complications of an unrecognised
malpositioned long line.2 We feel that aware-
ness of this radiological sign would facilitate
early recognition and would prevent serious
morbidity.
B C Schoonakker, D Harding
Department of Neonatology, UBHT, St Michaels,
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primary care fact or artefact?
Recently reported declines in asthma mor-
bidity1 may be difficult to interpret as they
could reflect not only changes in incidence,
but also changing disease severity, patient
expectations, healthcare provision, and effi-
cacy of pharmacological management.
Indeed, it has been suggested that general
practitioners may choose differing diagnostic
labels for respiratory disease to justify pre-
scribing medication.2
In view of these apparent inconsistencies,
we used 37 practices taking part in the
Scottish Continuous Morbidity Recording
project (CMR) to determine possible changes
in diagnostic fashion. Changes in the yearly
age specific incidence (per 1000 population)
were ascertained for the recording of diag-
noses and symptoms including asthma,
wheeze, and other respiratory illnesses
including acute bronchitis, bronchiolitis,
lower respiratory tract infection (LRTI),
croup, chest infection, and acute respiratory
infections combined (Read codes (version 2)
used listed in table 1). The CMR project’s
data collection processes have been described
previously.3 Two child age groups were
defined, namely those aged under 5 years of
age (n=12 693 children) and those aged 5–
14 years (n=30 165 children). Trends of
disease incidence for six 12-month periods













Figure 3 Reproduced with kind permission from British Journal of Radiology: RS Oeppen and K
Tung. Retrograde venous invasion causing vertebral metastases in renal cell carcinoma. Br J Radiol
2001;74:759–61.
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2002 were tested for linear association using
the Mantel-Haenszel x2 test, giving p for
trend using Epi Info version 6.0 (Centers for
Disease Control and Prevention, Atlanta,
Georgia, USA). The study protocol was
approved by the Scientific Advisory Group
of the Primary Care Clinical Informatics
Unit–Research, which is the registered guar-
dian for these anonymised data.
In the youngest age group, there was a
declining trend in the incidence of asthma
(p , 0.001), with the rate of wheeze inci-
dence more than doubling over the study
period. There was a small increase over the
study period in the number of patients
presenting with both asthma and wheeze
(n=16). Increases in the six year study
period were observed for all other diseases
considered as an alternative diagnosis for
asthma (diagnostic transfer) (p , 0.001).
Overall, there was an increase in incidence
rates for those recorded as having any one
study disease or symptom (p , 0.001).
Similar trends for asthma and wheeze were
found for children aged 5–14 years.
In the present study, physician diagnostic
labelling has been shown to change with
time. There was a clear reduction in the
labelling of the incident cases of asthma and
evidence was also found for an increase in
other diseases and symptoms that could be
used as alternative diagnostic labels for
asthma. Although these changes may have
been influenced by British asthma guidelines
published in 1997,4 which reiterated the
importance of a correct diagnosis, changes
in computer coding procedures should not
have occurred, as a standard Read code
dictionary was used by trained CMR practice
data operators throughout the study period.
These trends may have implications for large
scale population surveys or studies that
utilise data collected from routine clinical
activity, leading to the accidental reporting of
artefact.
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Patient choice in medicine taking:
religious sensitivities must be
respected
Children often do not have choice in medi-
cine taking, as it is typically their parents who
agree, on their behalf, to receive prescribed
treatments. Exploring parents’ (and wherever
possible also children’s) beliefs about choice
of medication is however important,1 parti-
cularly so when strong religious beliefs about
Table 2 Annual incidence of asthma and wheeze and lower respiratory disease
combined in children under 5 years and 5–14 years
Diagnosis Year
1st diagnoses Incidence per
1000
95% CI
Incident cases, n Lower Upper
Under 5 years old
Asthma* March 1997 277 21.8 19.4 24.4
March 1998 256 19.7 17.5 22.3
March 1999 250 19.4 17.2 21.9
March 2000 195 15.1 13.4 17.7
March 2001 190 14.9 12.9 17.1
March 2002 211 16.6 14.5 19.0
Wheeze* March 1997 51 4.0 3.1 5.3
March 1998 65 5.0 3.9 6.4
March 1999 120 9.3 7.8 11.1
March 2000 135 10.5 8.9 12.4
March 2001 112 8.8 7.3 10.6
March 2002 123 9.7 8.1 11.6
Diagnostic
transfer*
March 1997 1007 66 51.04 84.00
March 1998 1032 69.3 53.94 87.69
March 1999 1024 86 68.78 106.24
March 2000 1104 102.2 83.35 124.07
March 2001 1161 104.1 85.06 126.15




March 1997 1265 99.38 80.80 120.98
March 1998 1291 99.48 80.89 121.08
March 1999 1326 102.86 83.94 124.80
March 2000 1353 104.96 85.84 127.09
March 2001 1387 108.67 89.20 131.16
March 2002 1450 114.24 94.25 137.24
5–14 years old
Asthma* March 1997 360 13.1 11.8 14.5
March 1998 399 13.8 12.5 15.2
March 1999 371 12.3 11.1 13.6
March 2000 302 10.0 9.0 11.2
March 2001 281 9.3 8.3 10.5
March 2002 308 10.2 9.1 11.4
Wheeze* March 1997 30 1.1 0.8 1.6
March 1998 48 1.7 1.3 2.2
March 1999 53 1.8 1.4 2.3
March 2000 68 2.3 1.8 2.9
March 2001 58 1.9 1.5 2.5
March 2002 61 2.0 1.6 2.6
Diagnostic
transfer*
March 1997 594 21.54 13.41 32.81
March 1998 657 22.76 14.37 34.28
March 1999 570 18.93 11.36 29.64
March 2000 516 17.14 9.99 27.45
March 2001 654 21.68 13.52 32.98




March 1997 950 34.45 23.91 48.08
March 1998 1067 36.97 26.01 51.00
March 1999 968 32.15 22.00 45.40
March 2000 856 28.43 18.94 41.03
March 2001 968 32.09 21.95 45.33
March 2002 1086 36.00 25.20 49.88
*Mantel-Haenszel x2, p,0.05.
Table 1 Respiratory illnesses
studied; Read codes
Respiratory disease Read code
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contents of medications may be present, as a
failure to do so may result in unintended
harm and negatively impact on compliance.
In a multicultural context, it is essential
that prescribers have a minimal level of
awareness of parent’s religious sensitiveness
so that these can be considered when
prescribing (table 1). Jehovah’s Witnesses,
for example, may choose to avoid blood
derived products.2 Jewish law forbids any
oral use of medication containing glycerol,
stearates, lactose, and porcine products.3
Similarly, Hindus and Sikhs may be offended
by medication containing animal products,
particularly bovine derived products (for
example, gelatine containing capsules).
Islamic rulings that prohibit any systemic
ingestion of pork or alcohol also need to be
considered in the context of prescribing
decisions involving Muslims.4
A practical way of ensuring that health
professionals have sufficient information
about treatment options available would be
for the British National Formulary to clearly
indicate which preparations contain blood,
animal, and alcohol derivatives, and, where
possible, suggest suitable alternatives. The
proposed electronic health records will facil-
itate the seamless sharing of patient informa-
tion among multiple healthcare providers.
This will therefore offer an additional sys-
tematic approach for routinely collecting
information, and through use of ‘‘prescribing
alerts’’ can help inform clinicians about
patient preferences in relation to medica-
tions.
But beliefs need to be balanced against
clinical need. Recognising that many reli-
gious traditions offer a degree of relaxation of
their respective laws in extenuating circum-
stances, there may be a need to work
pragmatically with faith leaders to find
acceptable compromises in cases where sui-
table treatments or treatment regimens do
not exist, for example in the case of
pancreatic preparations, which are all porcine
in origin (table 1).
Stereotyping must however be avoided.
Arguably, even more important than knowl-
edge of the main tenets of different faiths
and access to information about the consti-
tuents of medicines then, is that prescribers
have the skills and attitudes to explore
patients’ own beliefs and preferences during
prescribing consultations. Parents and chil-
dren are not passive recipients of prescribing
decisions; they have their own views which
are a key influence on whether and how they
take medications and these must be
respected.
A R Gatrad
Manor Hospital and Birmingham University, UK
G Mynors
Medicines Partnership, London, UK
P Hunt
National Patient Safety Agency, London, UK
A Sheikh
Division of Community Health Sciences: GP Section,
University of Edinburgh, Edinburgh, UK
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Lessons from an unsuccessful
local attempt to tackle childhood
overweight and obesity
While we greatly enjoyed Mary C J Rudolph’s
‘‘Best Practice’’ article on ‘‘The Obese Child’’,1
we cannot agree with her conclusion that
obesity fulfils most of the criteria for a
condition that justifies screening. Our own
local experience in Solihull, West Midlands,
might illustrate this point.
Using a grant from the Children’s Fund
(www.cypu.gov.uk/corporate/childrenstrust/
index,cfm) we aimed to set up a ‘‘Fit Club’’
serving children aged 7–11 in seven wards in
Solihull, with DETRI deprivation indices
ranging from 7.53 to 54.49. All seven wards
contain enumeration districts with depriva-
tion indices in the worse 15% of the country.
We attempted to recruit 20 children, for an
initial consultation phase, in which they and
their families would be able to discuss with
our multidisciplinary team the kinds of
services they would like to tackle the child’s
weight. They would be able to try out various
exercise programmes if they wished, as well
as receiving dietetic advice, and as an
incentive we also offered £10.00 worth of
fresh fruit and vegetables. The only criterion
for recruitment was that the child should be
perceived to have a weight problem both by
their family and professionals.
We attempted to recruit children via con-
tact with school nurses, recommendation
from general practitioners, and an advertise-
ment in the local paper. To our disappoint-
ment, we found that we were able to recruit
only four children. GPs had forwarded seven
names, of whom one actually made contact
with the service, while the school nurses
informally fed back that families felt that
their child’s weight was not an issue on
which they needed to take action. A final
attempt at recruitment, based on one large
primary school with support of teaching staff,
was similarly completely unsuccessful. It
would seem likely that a difference in
perception of the seriousness of overweight
and the need for action between parents and
professionals explained our disappointing
outcomes.2
Our experience thus leads us to believe that
detecting obese or overweight children by
screening will not substantially alter the scale
of these problems on a population basis,
although services for those that do request
them are clearly justified.
N Haisman, K A Matyka, A Stanton
Solihull Primary Care Trust, West Midlands, UK;
haismann@hotmail.com
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Author’s reply
Drs Haisman, Matyka, and Stanton describe
their disappointing and frustrating experi-
ence of offering a programme for obese
children. However this experience cannot be
used to argue that screening would have no
value.
My comment that obesity fulfils most of
the criteria for screening was based on the
fact that: it is a common condition with
serious consequences; it can be identified in
its early stages; and it is potentially reversible.
If it was reversed the costs of identifying
obese children would be more than offset by
the savings in health care later. The big ‘‘but’’
is the one (and very major) problem that we
cannot offer effective treatment. If we can
resolve that, then undoubtedly we should be
screening our school age population.
The Solihull experience is not universal.
With current sympathetic media interest the
climate is changing and we are finding that
Table 1 Examples of bovine, pork, and blood derived mediations and possible
alternatives
Blood, bovine, and pork derived mediations Alternative preparations
(generic and proprietary names) (generic and proprietary names)
Blood
Human albumin Crystalloid e.g. saline
Factor VIII Recombinant factor VIII
Bovine
Amoxicillin (Amoxil) capsules Amoxicillin (Amoxil) syrup
Beef insulin Recombinant insulin
Omeprazole (Losec) Omeprazole (MUPS) dispersible tablets
Pork
Portant alfa (Curosurf) Colfosceril palmitate (Exosurf)
MMR vaccine (MMR-II) MMR vaccine (Priorix)
Heparin calcium (Calciparine) Heparin (Arixtra)
Isophane insulin (Hypurin) Isophane insulin (Human insulatard)
Pancreatin (Pancrease) No alternative
Competing interests: ARG and AS have (voluntary)
positions with the Research and Documentation
Committee of Muslim Council of Britain. They, together
with GM, were involved in the production of Informed
choice in medicine taking: drugs of porcine origin and
clinical alternatives which was supported by an
unrestricted educational grant from Sanofi-
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families are seeking help. Our WATCH IT
community based programme in Leeds has
65 children enrolled with good attendance
and we now have a waiting list.
Rather than dismiss the idea of screening
at some point in the future, let us argue for
more resources to develop clinically effective
interventions.
M C J Rudolf
Department of Community Paediatrics, Belmont
House, 3–5 Belmont Grove, Leeds LS17 8DR, UK;
mary.rudolf@leedsth.nhs.uk
Patterns and risks in spinal
trauma: the emergency transport
perspective
The article by Martin and colleagues1 review-
ing patterns and risks in spinal trauma
highlights the increased incidence of spinal
cord injury (SCI) and spinal cord injury
without radiological abnormality
(SCIWORA) in young children. They suggest
that without clinical suspicion proper evalua-
tion of the child’s spine may not occur, and
refer to an audit by Skellet and colleagues2
that shows inadequate spinal immobilisation
of paediatric trauma patients on arrival of the
paediatric retrieval team.
Preventing secondary injury during trans-
fer (movement of patients between hard
surfaces in close proximity) and transport
(patient movement between facilities) is
particularly important.
There are a number of devices available to
facilitate spinal immobilisation during trans-
fer and transport. These include spinal board
(SB), vacuum mattress (VM), patslide, and
scoop device in combination with traditional
hard collar, blocks, and tapes to provide
cervical spine immobilisation
We carried out a survey to identify the
current practices in immobilisation, transfer,
and transport of the paediatric trauma
patient with actual or potential SCI. Postal
questionnaires were sent to the retrieval
coordinators in 18 UK paediatric ICUs asking
about methods of spinal immobilisation
during transfer and transport of paediatric
trauma patients and existence of guidelines
for management of that population.
There was a 100% response rate (postal
plus follow up phone calls to two centres).
Only 27% (5/18) of retrieval services
employed practice guidelines. For patient
transfer, 27% (5/18) of retrieval services
utilised a patslide device alone and 50% (9/
18) utilised a patslide in combination with a
vacuum mattress and/or spinal board
(table 1). For patient transport, 67% (12/18)
of services had a consistent approach
(table 2). A spinal board, either alone or with
padding, was used by 72% (13/18) of services
for at least some of their patient transports.
One hundred per cent of services used the
traditional triad of hard collar, sandbags/
blocks, and tape/straps for maintaining cer-
vical spine immobilisation.
As Martin et al have described, SCI and
SCIWORA occur more frequently in younger
children. Without an obvious radiological
abnormality, these injuries may potentially
be overlooked. Prevention of secondary injury
is thus important during transport of at risk
patients. Our survey illustrates that there is a
lack of a consistent approach to spinal
immobilisation during transfer and transport
of paediatric trauma patients. There is also
continuing use of spinal boards despite
evidence that they should only play a role
during extrication of patients in the pre-
hospital setting3 and that vacuum mattresses
may confer benefits in terms of patient safety
and comfort.4
The development of best practice guide-
lines may lead to a more consistent approach.
S A Russ, S W Hancock, M Quinton, R Moore
Sheffield Children’s Hospital, UK
P Harrison
Princess Royal Spinal Injuries Unit, Sheffield, UK
Correspondence to: Dr S W Hancock, Consultant
Paediatric Intensivist, Sheffield Children’s Hospital
Retrieval Service, UK; stephen.hancock@sch.nhs.uk
doi: 10.1136/adc.2005.072546
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Dapsone therapy for Henoch-
Scho¨nlein purpura: a case series
Henoch-Scho¨nlein purpura (HSP), first
recognised by Heberden in 1801, is a
systemic, IgA mediated vasculitis of small
vessels that is usually self-limiting but may
progress to gastrointestinal bleeding, intus-
susception, and nephropathy. A third of
patients will experience recurrences.1
Currently treatment is confined to rest,
analgesia, and steroids for refractory abdom-
inal pain,2 and immunosuppressants for
complications, especially renal disease.
Original reports, predominantly in adults,
show that the symptoms of purpuric rash,
abdominal pain, and arthritis in HSP respond
to treatment with dapsone.3–5
Even though the first case of HSP treated
with dapsone was reported in 1983, it is still
not generally recognised as a treatment for
HSP. We describe eight children in whom,
because of the severity or persistence of their
symptoms, treatment with dapsone was
commenced from among 41 patients diag-
nosed with HSP from January 1992 to May
2004. All gained a clinical response from
treatment with the most beneficial effect on
the skin rash. The demographic characteris-
tics of the patients and their presenting
clinical features as well as treatment are
shown in table 1. The rash improved within
3 days to 1 week of starting treatment with
dapsone in all patients. Six of eight relapsed
when treatment was stopped, but responded
again to treatment. The side effects are dose
related and uncommon at doses commonly
used (1–2 mg/kg daily).
Dapsone, an antileprotic drug, used for a
variety of dermatological conditions, appears
to be of special value in diseases characterised
by accumulation of neutrophils, notably with
leucocytoclastic vasculitis, of which HSP is an
example. There is evidence that it has anti-
oxidant scavenger effects and may suppress
the generation of toxic free radicals in
neutrophils. It also inhibits prostaglandin D2
production and synthesis of IgG and IgA
antibodies.6 It may also inhibit IgA–neutrophil
interactions.3 Given the pathogenesis of HSP
with IgA mediated vasculitis, treatment with
dapsone represents an exciting form of treat-
ment. The clinical course of our patients
suggests that dapsone controls the cutaneous
vasculitis rather than cures it. As steroids may
mask the features of more ominous intestinal
disease, dapsone can be a reasonable alter-
native. Nonetheless, to date there is no
evidence of a positive effect on renal disease.
In conclusion, dapsone is a drug that may
have a role in the treatment of HSP. In order
to establish its usefulness it is necessary to
conduct a multicentre, placebo, randomised
controlled trial.
Informed consent was obtained from par-
ents before starting treatment with dapsone.
H Iqbal, A Evans
Queen Elizabeth Hospital, London, UK
Correspondence to: Dr H Iqbal, Department of
Paediatrics, Queen Elizabeth Hospital, Stadium Road,
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Table 1 Methods of patient
transfer (n = 18)
No.
Patslide alone 5
Patslide + VM 1
Patslide + SB 4
Patslide + VM or SB 4
Scoop + SB 2
VM alone 1
SB alone 1
Table 2 Methods of patient
transport in services with a
consistent approach (n = 12)
No.
VM alone 4
VM + SB 1
SB alone 2
SB + padding 4
Trolley only 1
Competing interests: none declared
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If community paediatricians did
not exist, it would be necessary to
invent them
Since 1991 there has been talk of abolishing
community paediatrics as a specialty.1 At that
time, a group of related specialties was
proposed: a specialty of child development
and rehabilitation (neurodisability); child
protection would be subsumed into general
paediatrics and there would be child public
health doctors. Since then there has been a
view among some paediatricians that com-
munity paediatricians should become the
general paediatricians of the future.2 3 Dr
Chambers’ recent article proposes a narrow
view of community paediatrics, concentrating
on chronic illness and confining its role to
diagnosis and medical management.4 He
rather misses the point.
The challenge of community
paediatrics
Children do not come in neat packages, with
diagnostic labels. They and their families
need all their needs met. Hospital practice
traditionally concentrates on the illness, not
the patient, although this is becoming less
with time and paediatricians have always
been more holistic than adult counterparts.
Hospital practice often deals with complex
problems by having specialists for each
problem. Our adult physician colleagues are
beginning to realise that doesn’t work and
are reinventing the general physician.
It has been shown that community pae-
diatric patients have significantly more com-
plex problems than those presenting to
general paediatricians.5 Many of the condi-
tions we diagnose and treat have no diag-
nostic tests. Community paediatricians need
excellent clinical skills, must be able to
manage complexity and uncertainty, and
must have the ability to communicate across
disciplines and across agencies, creating
understanding in those who come from
different backgrounds and with different
agendas. It is not an easy job.
The National Service Framework
The NSF was constructed by multidisciplin-
ary groups including parents. It is therefore
no accident that child health, not illness, is
emphasised. Hospital practice has rather less
emphasis than crosscutting ‘‘out of hospital’’
issues. Communication, coordination, and
early intervention are all key themes.
Parents and our sister agencies value medical
input that is holistic, available where it is
needed (not just in the clinic), and attuned to
the needs of the child and family in the
community. They demand more of it than we
can currently give. Nevertheless, child health
outside hospital has moved up the agenda
and it will be hard for local authorities to
deliver Every Child Matters without focused
child health support to education, social, and
voluntary services, as well as child health per
se. This new agenda requires exactly the skills
community paediatricians have. If commu-
nity paediatricians did not exist, it would be
necessary to invent them to deliver the NSF.
The challenge is how we tackle it.
Dr C M Ni Bhrolchain
Consultant Community Paediatrician, Wirral Hospital
NHS Trust, UK; cliona_nib@lineone.net
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Melatonin: a panacea for
desperate parents? (Hype or
truth)
Sleep disorders are common in children with
neurodevelopmental disorder and are a major
source of stress for the whole family. In
children with neurodevelopmental disabil-
ities the prevalence may be as high as 80%.1
The current literature is suggestive of circa-
dian rhythm dysfunction, social difficulties,
and abnormal melatonin levels in children
with autism.2
Hypnotics and sedatives can produce side
effects and tolerance,3 so is melatonin the
answer in children with sleep problems asso-
ciatedwith severe developmental difficulties of
social and communicating nature, which have
not responded to behavioural and social mea-
sure? Previous studies and case reports have
suggested that melatonin could be effective.
We retrospectively reviewed cases of nine
autistic children with chronic sleep disorder,
who were attending the Child Developmental
Centre at Windmill Lodge. The age range of
these children was 2–11 years. No additional
non-pharmacological sleep intervention was
instituted. They were started on 2.5–5 mg
melatonin 45 minutes before their sleep-
ing time. In four of these patients sleep
latency was reduced. Our own experience of
reduction in sleep latency is in accordance
with literature.4 Five parents reported
improvement in total duration of sleep. In
Competing interests: Dr Ni Bhrolchain in a Specialty
Training Advisor in Community Child Health. These
views are her own.
Table 1 Demographic characteristics, presenting clinical feature, and treatment of the patients
Patient
1 2 3 4 5 6 7 8
Age at presentation 22 m 8 y 8 y 5 K y 10 y 5 y 8 y 10 y
Sex F F F M F F M F
Race White White White White White White Vietnamese White
Prodrome 2 Sore throat 2 2 Diarrhoea Pustules 2 Tonsillitis
Presenting features
Miserable + 2 2 2 2 2 2 2
Rash + + + + + + + +
Joint pain 2 + + 2 + + 2 +
Joint swelling + 2 + 2 + + 2 2
Abdominal pain 2 2 + + 2 + + 2
Vomiting 2 2 2 + 2 + + 2
Swollen testicle 2 2 2 + 2 2 2 2
Haematuria 2 + + 2 + 2 + +
Proteinuria 2 + + 2 2 + + 2
Rectal bleeding 2 + 2 2 + 2 2 +
Length of presentation 1 d 2 d 2 d 1 d 5 d 4 d 5 d 1 d
Presentation to
treatment
10 d 14 m 4 m 18 m 5 d 8 d 11 d 1 m
Dose 1 mg/kg od 1.3 mg/kg od 1 mg/kg od 1.25 mg/kg od 0.75 mg/kg bd 1 mg/kg od 1 mg/kg od 0.5 mg/kg bd
Length of first course 6 d 7 d 4 d 4 w 10 d 7 d 14 d 10 d
Positive response Yes Yes Yes Yes Yes Yes Yes Yes
Relapse after first
course
No Yes No Yes Yes Yes Yes Yes
Total duration of
treatment
6 d 7 d 4 d 2 K y 8 m 5 w 5 w 2 y
d, day; w, week; m, month; y, year; +, present; 2, absent; od, once a day; bd, twice a day.
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three patients medication was stopped within
a week because of no response. Four patients
are still on melatonin for over a year without
any side effects. We could not find the cause
in non-responders.
To find out the real benefit of melatonin,
the dose, short and long term side effects,
and group of patients who will respond to
melatonin, several authors have already
identified the need for a double blind cross-
over study.4 Previous studies have reported
response rates of up to 80%,5 6 but it is seems
likely that studies which group together child-
ren with ‘‘neurodevelopmental disorders’’ in a
generic manner will not furnish the answer as
to the true place of melatonin in the
management of disturbed sleep patterns.
R Gupta
Ealing Hospital NHS Trust, London, UK
J Hutchins
Ealing PCT, London, UK
Correspondence to: Dr R Gupta, Department of
Paediatrics, Ealing Hospital NHS Trust, Uxbridge
Road, Southall, London UB1 3EU, UK;
reeta_pradeep@yahoo.com
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An integrated care pathway for
looked after children can
facilitate multi-agency
coordination
Looked after children are a vulnerable popu-
lation at risk of unidentified and unmet
health needs. Coordinated input from health,
social care, and education services for these
children is required by government but is not
easily achieved.
The focus on looked after children has
sharpened with the Quality Protects pro-
gramme, a major initiative launched in 1998
to improve their life chances. In 2002, the
Department of Health (DH) published gui-
dance on how to develop a health service for
looked after children.1
‘‘Children in special circumstances’’, includ-
ing looked after children, are prominent in
the National Service Framework (NSF) for
Children Young People and Maternity
Services. Implementation of the DH guidance
is explicitly required by the NSF.
The Children Act 2004 sets out a new
framework for children’s services with
Directors of Children’s Service and Lead
Members for children in each local authority.2
The government is establishing Children’s
Trusts to drive the coordination and integra-
tion of planning, commissioning, and delivery
of health, social care, and education services.
How are these agencies to work together
more effectively? There are well recognised
facilitators and barriers to coordinating
multi-agency practice.3 Poor communication
between agencies and a lack of understand-
ing of each other’s roles and responsibilities
has been a barrier and is a recurring feature
in reports of child abuse and child deaths.
An integrated care pathway (ICP) is a health
sector concept that ‘‘determines locally agreed
multidisciplinary practice based on guidelines
and evidence, where available, for a specific
patient user group. It forms all or part of the
clinical record, documents the care given and
facilitates the evaluation of outcomes for
continuous quality improvement’’.4 The ICP
concept is multifaceted and complex but con-
sists of both a process (of development and
continuing maintenance) and a set of opera-
tional products. It can usefully be extended as
a tool to improve multi-agency working.
An ICP to promote the health of looked
after children has been developed in
Birmingham. The products include a process
map, updated health assessment documenta-
tion, and a variance reporting strategy.5
At its best an ICP can be a mechanism to
enhance collaborative working across agen-
cies for specific populations such as looked
after children.
D Simkiss
Division of Health in the Community, Warwick
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BOOK REVIEWS
is an extremely useful educational resource.
The DVD was commissioned due to the
concern of the Department of Health in
England about door-to-needle times for
meningococcal disease in children. The aim
was to set up a video teaching package for
A&E doctors and paediatricians about recog-
nition of serious illness in childhood. The
original remit was extended to include GPs,
paramedics, emergency care practitioners,
and others assessing children. I noticed that
all the consultants received a copy as part of
the Children’s National Service Framework
package and it looked interesting. The car-
toon representations on the cover artwork
show a worried-looking doctor bemused by
caricatures of spotty, crying, febrile, and
flushed children. This simple and inviting
imagery nicely reflects the subject matter.
The DVD uses an interface which will be
familiar to most. Seven menus, covering the
top presenting emergency symptoms in child-
hood, function as gateways to symptoms
based tutorials. This simple menu system is
useful to get to a particular section quickly.
But there is no opportunity to interact with
clinical material or cases, or for making
management decisions.
The opening sequence contains many of the
images we will see during the DVD set to a
symphony of crying, coughing, and calming
background banter from parents, nurses, and
doctors. It might put off healthcare profes-
sionals who are not used to this sort of
decorum in a paediatric A&E, but it is a cute
way to introduce the content. Following this
there is a head-to-head edited interviewwith a
‘‘TV doc’’ and an A&E consultant (you can
skip the entire intro at the push of a button).
The conversation makes interesting watching
as the TV doc tries to justify why spotting a
sick child is so important. The A&E consultant
gives a far more grounded perspective to
assessing children in the clinical setting. The
TV doc suggests there is a culture of practicing
defensive medicine, but the A&E consultant
(much more the voice of reason) declares it is
more to do with human nature that we try our
best to spot the sick child and not miss
something important. Surely safe medicine is
defensible and that should be the focus.
There are many great video clips shown,
often with explanatory narrative and some
with a visual caption. Being involved in a
similar project locally to capture video of
acute presentations and clinical signs for
teaching I can appreciate the time and effort
put into obtaining useable footage as well as
the goodwill of patients and their parents.
Some of the clips within each section are
repeated—the same breathless baby, croupy
cough, or miserable infant. But that is
reinforcement and a useful educational tool.
The ‘‘red flags’’ are particularly helpful,
although some are no more than a ‘‘talking
head’’ explaining a worrying symptom or
making a learning point without any video or
visual aid to back up or reinforce the point.
It is worth mentioning that along with
excellent footage of symptoms, signs, and
clinical evaluation is a lot of talk. The team of
presenters use a formal and didactic delivery
style, assiduously reading their script from an
autocue. The tone is serious which is appro-
priate for the topic material, but paediatrics
can be a fun and up-beat speciality. Most sick
children do get better!
I liked the 3 minute toolkit showing how an
examination can be completed with the child
on the mother’s knee. I always think is nice to
ask younger children if I can examine them
Spotting the sick child (DVD)
Edited by Ffion Davies. University Hospital of
Leicester and Royal College of Paediatrics &
Child Health, 2004, £8.99 single copy, or £6.46
for orders of six or more. ISBN 1 904039 11 1
This innovative joint project between the
Department of Health and the Royal
Colleges of Accident and Emergency
Medicine and Paediatrics and Child Health
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but am in trouble if they defiantly say ‘‘no!’’. I
did not find any tips to deal with children who
are difficult to examine. One highlight among
the many excellent clips showing physical
signs was the examination of the child with
peritonitis. He winces and holds his abdomen
rigid, even pushing the examining hand away.
Watching such an examination is then next
best thing to examining the child yourself,
certainly better than a didactic session on
clinical examination.
This DVD is a powerful, versatile, and
informative resource which will be able to
offer many healthcare professionals in all
specialties and at all levels of training insight
into how an ill child might look in practice.
This is most useful in current times with the
usual arguments over reduced time in train-
ing and the reduction in working hours.
Anyone would feel more skilled after spend-
ing time with this DVD. I hope it will help to
demystify the paediatric assessment and give
those clinical signs which we strive to explain
a real and ‘‘live’’ feel. This DVD, with its
instructive and common-sense approach,
should take pride of place in induction
programmes and would be a valuable teach-
ing resource in any A&E department, pae-
diatric unit, or GP surgery. Overall it
definitely does what it says on the box.
A Reece
Immunization in practice, a practical
guide for health staff
World Health Organisation, 2004, pp 230,
J31. 13 (paperback book and CD-ROM). ISBN
92 4 154651 4
There have been some great successes in
global immunisation in the last decade with
the near eradication of polio and reductions
in neonatal tetanus. In some developing
countries childhood immunisation coverage
is increasing, but in others it is still extremely
low; for example, only 50% of infants in Sub-
Saharan Africa compared to the United
Nations goal of 90%. There is still great
inequality between wealthy and low income
countries in access to and delivery of safe
vaccination. Thus there are millions of the
most vulnerable children at risk of life
threatening and disabling diseases.
The challenge of global immunisation
Leaving political and economic problems
aside, how can immunisation rates in devel-
oping countries be improved and sustained?
This book aims to provide a resource of
practical and management skills to health
workers in developing countries to reach this
goal, and could equally be used as a training
manual. It is the result of work between
many organisations including the WHO,
Children’s Vaccine Program, and UNICEF. It
covers the common target diseases and their
vaccines, and aims to promote the use of
underused vaccines such as Hib, yellow fever,
and hepatitis B. The immunisation schedule
is based on the ‘‘Expanded Programme on
Immunisation’’ and includes combination
vaccines, for example, DTP-HepB + Hib. The
book would need to be used in conjunction
with up to date national policies and vaccine
schedules, which vary between countries and
are regularly changing as new vaccines are
introduced. The book is divided into eight
modules with summary tables to emphasise
key points and clear diagrams. It covers
the practical aspects of delivering effective
immunisation in great detail, for example,
the cold chain including details of transport
and refrigeration. It explains how to make a
homemade sharps container and how to
dispose of them, from incineration to burying
in a disposal pit. Information on the diseases,
vaccines, and side effects is quite brief, but
practical.
The module on holding an immunisation
session emphasises safe practice to reduce
needle stick injuries, including how to set up
a clinic, injection techniques, and adopting
autodisable syringes to prevent reuse.
Strategies are listed to improve coverage by
developing a district plan from fixed, out-
reach, and mobile clinics, estimating vaccine
needs, and on building links with the local
community. Further modules cover the mon-
itoring and recording of data.
This book is designed for developing
countries and would be less useful for health
professionals in the UK. It does not cover
many of the new vaccines used in the UK, for
example, conjugated pneumococcal or
meningococcal vaccines, which are not prio-
rities in developing countries. However, the
practical sections on holding an immunisa-
tion session set clear quality standards which
should be adopted by any organisation
delivering an immunisation clinic. Up to date
information on the UK immunisation sche-
dule can be found online in the ‘‘Green
Book’’ and its updates at http://www.immu-
nisation.nhs.uk/ under the publications sec-
tion. The full version of this book can be
found online at http://www.who.int/vac-
cines-documents/DoxTrng/h4iip.htm. Overall
this book will be a valuable tool in the global
challenge of delivering safe and effective
immunisation to all children.
A Isaacs
Key topics in neonatology, 2nd
edition
Edited by Richard H Mupanemunda, Michael
Watkinson. London: Taylor & Francis, 2005,
£28.95, pp 420. ISBN 1859962343
The second edition of
Key topics in neonatology
claims to provide a
quick and very up to
date summary of cur-
rent concepts in neo-
natology, in a self
contained and easily
readable problem
based format for neo-
natal trainees and
nurses. The authors re-
commend the text as
an ideal revision aid for MRCPCH and DCH
candidates. The book is very compact and has
just over 400 pages, with common neonatal
problems arranged alphabetically, which we
found easy to use.
The authors do acknowledge that some
topics reflect their personal practice; however
each topic ends with a useful reading list and
related topics of interest, which encompasses
other contemporary views. References to
family support groups are also helpful.
The majority of sections give good, clear,
concise advice and certainly fulfil the role of a
revision text. However, we would like to have
seen cardiac tamponade included as a cause,
in the section on acute neonatal collapse, and
the use of echocardiography in the list of
investigations to exclude this. The session on
ambiguous genitalia was weak, mainly
because of the incorrect premise that 90% of
cases are females with congenital adrenal
hyperplasia. The authors have decided to
cling on to outmoded terms such as ‘‘nesi-
dioblastosis’’ and ‘‘hermophrodite’’, and the
‘‘Papile’’ classification given for grading of
intracranial haemorrhage.
Because of the problem based format, some
topics were necessarily repeated, and there
were some inconsistencies in recommenda-
tions in different sections of the book. For
example, hepatitis B immunoglobulin is
recommended to be given within 24 hours
in one section and within 48 hours in
another. The normal anion gap is given as
6–14 in one place and as 8–16 in another.
Inconsistencies were also noted in cord
haemoglobin and bilirubin values for recom-
mended early exchange transfusion.
There was an excellent ‘‘special notes’’
section with a discussion of the appropriate-
ness of different types of volume replacement
and inotropes in hypotension. We would
have liked to see similar sections surrounding
some other controversial subjects and man-
agement issues. Despite suggesting that
saline should be the usual fluid of choice, it
appears that the authors’ practice is to use
blood products in their clinical management,
in other areas of the text.
We decided to do a test run using the book
to see if it matched up with the authors’
claims that it is a quick reference book in the
neonatal unit, by referring to the book, to
guide us in management on a few admissions
to the neonatal unit.
The first clinical scenario was a baby whose
mother was diagnosed with maternal HIV
after delivery. In less than a minute we had
detailed information on perinatal HIV man-
agement along with web addresses of useful
links—impressive indeed! Unfortunately in
the five page chapter on HIV, only half a page
was dedicated to neonatal prophylaxis. There
is no mention about the ethical and legal
issues when a mother refuses antenatal or
postnatal HIV testing. The text did not help in
the management of the baby in this case;
however the cited excellent website of
‘‘Bhiva’’ came to the rescue in deciding what
precise treatment need to be given.
The second scenario was a baby with
pulmonary hypertension where we wanted
check formulas for oxygenation index and
AaDO2. Again within seconds, everything
was in front of us. Although we wanted to
check the length to which umbilical arterial
catheter should be inserted for this baby, we
were disappointed as there was no mention
of a formula anywhere.
The third scenario was the counselling of a
mother with antenatally diagnosed ventricu-
lomegaly in the fetus. Unfortunately this was
not mentioned anywhere in the book.
However, there was very detailed information
on the ‘‘Epicure study’’ and neurodevelop-
mental outcome of babies born at extremes of
viability. This will be very handy information
for neonatal registrars in counselling expec-
tant mothers in preterm labour.
The final scenario for the test run was to
ascertain the investigation and drug therapy
for an 8 week old premature baby with
conjugated jaundice. The topic is described
in great detail under both jaundice and
liver disorders, and there is a huge list
of causes of neonatal hepatitis. Inclusion
of conditions such as erythrophagocytic
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lymphohistiocytosis and ARC syndrome
made us acutely aware that the book is from
Birmingham!
In summary, this book would be a useful
edition to neonatal units as a rapid reference
guide, particularly for the excellent web links.
The layout of the book is very practical and in
a problem oriented style. The lists given under
‘‘aetiology’’ of most conditions are exten-
sive and theoretical, but will be a helpful
revision aid for junior doctors and nurses.
S Thayyil, A L Ogilvy-Stuart
Prevention of allergy and allergic
asthma: World Allergy Organization
project report and guidelines
Edited by S G O Johnsson, T Haahtela. Karger,
2004, J127.00 (hardback), pp 211. ISBN 3
8055 7810 5
Edited by two Scandinavian experts in the
field, this book is the result of a working
group of the World Allergy Organization
(WAO) and the WHO. With contributions
by authors from 21 countries it presents a
contemporary international overview and
consensus of what is known and not known
about prevention (primary, secondary, and
tertiary) of allergic disorders.
The introduction includes clear definitions
of some terms such as allergy and hypersen-
sitivity. It also sets out the useful instruction
to all the authors to include an evidence base
category with all references—and this book
cannot be criticised for a lack of references!
The genetics of allergy are then reviewed
in detail that is moderately technical but
highlights some of the problems with the
results from research to date, such as the
varying definitions of atopy (that is, pheno-
type definition) used in different studies.
Despite much effort and the advance of
molecular biology, there are still few new
certainties about the inheritance of allergy,
but strategies for future work are described.
Unsurprisingly, the longest chapter in the
book analyses proposed environmental influ-
ences causing asthma and allergy. Various
dietary factors from fish oils to food additives
are discussed. Topical issues such as the
hygiene hypothesis, the influence of immu-
nisations, antibiotics, and probiotics (live
microbial food components) are all examined
and the data presented concisely. What is
known about the benefits of breast feeding
and weaning is also summarised. The clearest
conclusion is that environmental tobacco
smoke is bad for allergic airways disease
and more governmental action is required.
Another chapter reviews the fascinating
issue of immunological influences on the
fetus and neonate, showing that significant
immune responses occur in utero, influenced
by passage of allergen from mother to fetus.
Subsequently, the interventions in infants
at high risk of developing allergy are con-
cisely analysed with regard to altering mater-
nal diet during pregnancy and lactation and
reducing household aeroallergens. Of clinical
relevance is the conclusion that there is no
evidence of a preventative benefit of soy
based compared with cows’ milk formulae.
‘‘Can I do anything to stop my child getting
asthma and/or eczema’’ is a concern of an
increasing number of parents. Paediatricians,
who are often faced with this question, do
not have easy access to specialist allergy
opinion at present, because allergy as a
medical specialty in the UK could itself be
considered to suffer from ‘‘failure to thrive’’.
Any paediatrician or clinician with an interest
in asthma, eczema, or food allergy (are there
any who don’t?) will find this book helpful.
For anyone drafting local ward and/or com-
munity guidelines for nutrition, weaning,
and allergy, it provides an evidence base
and also some suggested information sheets
and guidelines.
A minor criticism is that the subject index
suffers from restricted development.
In conclusion, this book would be a useful
resource for those interested in allergy within
specialist departments and also for reference




Kendrick D, Royal S. Cycle helmet ownership
and use; a cluster randomised controlled trial
in primary school children in deprived areas
(Arch Dis Child 2004;89:330–5). There were
two errors in the sample size calculation for
this article. The correct figures should be 93%
(not 90% in the calculation for helmet own-
ing) and 48.5% (not 44.5% in the calculation
for helmet wearing). Therefore, the sample
size calculation should read:
The study had 80% power to detect a
difference in the percentage of children
owning a helmet from 81% to 93% between
the 2 treatment groups.
and
It had 80% power to detect a difference in
the percentage of children always wearing a
helmet from 34% to 48.5%, at the 5%
significance level.
Pre-published book reviews
Book reviews that have been accepted for publication but have not yet been published in the
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Book reviews in Fetal and
Neonatal edition
The following book reviews are published in
this month’s Fetal and Neonatal edition:
N Managing newborn problems: a guide
for doctors, nurses and midwives
N Neonatal respiratory disorders, 2nd edn
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